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Abstract
Clostridium perfringens ε-toxin (ETX) is a potent pore-forming toxin responsible for a central
nervous system (CNS) disease in ruminant animals with characteristics of blood-brain barri-
er (BBB) dysfunction and white matter injury. ETX has been proposed as a potential causa-
tive agent for Multiple Sclerosis (MS), a human disease that begins with BBB breakdown
and injury to myelin forming cells of the CNS. The receptor for ETX is unknown. Here we
show that both binding of ETX to mammalian cells and cytotoxicity requires the tetraspan
proteolipid Myelin and Lymphocyte protein (MAL). While native Chinese Hamster Ovary
(CHO) cells are resistant to ETX, exogenous expression of MAL in CHO cells confers both
ETX binding and susceptibility to ETX-mediated cell death. Cells expressing rat MAL are
~100 times more sensitive to ETX than cells expressing similar levels of human MAL. Inser-
tion of the FLAG sequence into the second extracellular loop of MAL abolishes ETX binding
and cytotoxicity. ETX is known to bind specifically and with high affinity to intestinal epitheli-
um, renal tubules, brain endothelial cells and myelin. We identify specific binding of ETX to
these structures and additionally show binding to retinal microvasculature and the squa-
mous epithelial cells of the sclera in wild-type mice. In contrast, there is a complete absence
of ETX binding to tissues from MAL knockout (MAL-/-) mice. Furthermore, MAL-/- mice ex-
hibit complete resistance to ETX at doses in excess of 1000 times the symptomatic dose for
wild-type mice. We conclude that MAL is required for both ETX binding and cytotoxicity.
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Author Summary
Clostridium perfringens epsilon-toxin is a potent pore-forming toxin responsible for a dev-
astating central nervous system disease in livestock and has been suggested as a possible
environmental trigger for Multiple Sclerosis. Epsilon-toxin binds with great specificity to a
restricted number of host cell types and structures, for example gut epithelial cells, blood-
brain barrier endothelial cells, and myelin. While most pore-forming toxins achieve bind-
ing through specific interaction with respective receptors on the cell membrane, the recep-
tor for epsilon-toxin, however, is unknown. In this report we identify the Myelin and
Lymphocyte protein, MAL, as being necessary for binding and cytotoxic effects of epsilon-
toxin, and we show its second extracellular loop is critical in this novel function. At a phys-
iological level, mice homozygous for a targeted deletion of the MAL gene lack sensitivity
to epsilon-toxin whereas the toxin is lethal in wild-type mice. These observations lead to
the possibility that MAL is a candidate receptor for epsilon-toxin. However, we have not
demonstrated a physical interaction between epsilon-toxin and MAL.
Introduction
Clostridium perfringens is a gram-positive, spore-forming, anaerobic bacillus that is possibly
the most widespread pathogenic bacterium in the world [1, 2]. Conventionally, the species is
categorized into five toxinotypes, A-E, based on carriage of one or more of the major toxin
genes (alpha, beta, epsilon, or iota). C. perfringens types B and D carry the epsilon toxin (ETX)
gene [1, 2]. In all, the C. perfringens species produces a remarkable seventeen exotoxins, and of
these, ETX is by far the most deadly, ranked the third most potent Clostridial toxin following
botulinum and tetanus toxins [3]
The ETX-producing C. perfringens type B and D strains are less prevalent than the type A
strain and are best studied in ruminant livestock where colonized animals are susceptible to a
devastating enterotoxemia disease, which is characterized by loss of vision, paresis, ataxia and
other signs of CNS dysfunction [4–7]. C. perfringens type B or type D can be readily isolated
from cultures of animals with characteristic signs of ETX enterotoxemia [8–10].
In C. perfringens colonized animals, ETX is typically secreted into the intestinal lumen as a
32.9 kDa protoxin (pro-ETX) and enzymatically activated into a 29 kDa toxin by extracellular
trypsin, chymotrypsin, or a C. perfringens encoded lambda protease [11–15]. However, some
strains may be able to activate ETX intracellularly [16]. Activated ETX is then absorbed into
the bloodstream through partially understood mechanisms [17]. ETX demonstrates a unique
tropism for kidney [18], CNS endothelial cells, and brain [19, 20]. Within the bloodstream,
ETX encounters the CNS endothelium, causes disruption of BBB, and allows entry of toxin
into the brain [21–25]. Once in the brain, ETX binds with high affinity to white matter and this
is presumably responsible for its well-described effect of causing white matter lesions in sheep,
goats and mice[6, 19, 26–30]. In light of these observations, it has been hypothesized that there
may be a connection between ETX and MS [31]. Having obtained the first evidence supporting
this notion, we recently proposed that ETX is an environmental factor responsible for initiating
lesion formation in MS [32].
Despite its potency and unique tropism for CNS tissues, the mammalian receptor for ETX re-
mains unidentified. Based on prior investigation, it has been postulated that the ETX receptor is
a glycoprotein residing in detergent resistant membranes or lipid rafts [33–36]. ETX has also
been reported to bind to the extracellular domains of Hepatitis A Virus Receptor 1 (HAVCR1)
immobilized on paramagnetic beads [37]. However, although knockdown of HAVCR1 reduces
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ETX toxicity in previously susceptible cells [37], transfection of ETX-resistant cells with
HAVCR1 fails to confer ETX binding and/or susceptibility. These experiments suggest HAVCR1
contributes to ETX toxicity but is insufficient to confer ETX toxicity. Since ETX specifically binds
to distal collecting duct epithelium of the kidney [18, 38] and to myelin in the CNS [19, 23, 39,
40], and since the putative ETX receptor is thought to localize to lipid rafts, we searched the Na-
tional Library of Medicine databases for proteins residing within lipid rafts of distal renal epitheli-
um and myelin. The tetraspan proteolipid MAL [41, 42] uniquely fits these specific
requirements. Therefore, we sought to test the hypothesis that MAL is the ETX receptor.
The crystal structure of active ETX reveals an elongated structure with three principle do-
mains sharing structural and conformational homology with the aerolysin family of pore-
forming toxins[43]. Domain 1 contains the putative receptor-binding site and includes a clus-
ter of aromatic residues[44] within the N-terminus. An amphipathic beta-hairpin within do-
main 2 contributes to ETX insertion into the plasma membrane and channel architecture.
Domain 3 is thought to be involved in protein-protein interactions between monomers that
stabilize oligomers. The receptor-binding domain is distinct from the domain(s) required for
oligomerization. Pro-ETX binds to receptive cells with the same affinity as active toxin but
does not integrate into the membrane to generate pore-forming oligomers. Formation of the
heptameric pore requires cleavage of the carboxy-terminal 22 amino acids [45, 46]. Upon bind-
ing to susceptible mammalian cells, ETX monomers form a heptameric prepore [47], which in-
serts into the plasma membrane generating a stable asymmetric pore of ~500 Da exclusion
[48].
MAL is a highly hydrophobic, tetraspan membrane proteolipid with two extracellular loops.
It is found in particular polarized epithelial cells [49], oligodendrocytes [42, 50, 51] and human
T lymphocytes [52]. In human T cells, MAL is expressed on the plasma membrane and is im-
plicated in the formation of immunological synapses [53, 54]. In the nervous system, MAL is
expressed by oligodendrocytes and Schwann cells and localizes to compact as well as non-com-
pact myelin membranes, and is thought to play a role in myelin biogenesis and function [55].
In polarized epithelial cells, MAL localizes to the apical membrane and is thought to shuttle be-
tween the Trans-Golgi-Network (TGN) apparatus and the plasma membrane, sorting apically
associated membrane proteins to the surface [56, 57]. Moreover, MAL plays critical roles in the
formation, stabilization and maintenance of lipid rafts [54, 55, 57–64]. Through a combination
of gain and loss of function experiments we show that MAL is required for binding and activity
of ETX.
Results
Specific binding of active ETX to its receptor is necessary for prepore assembly since resistant
cells fail to form heptamers even at high concentrations of ETX [47]. If MAL is required for
binding of ETX to cells, then expression of MAL in ETX-resistant cells should confer binding
of the toxin and render the cells susceptible to ETX-mediated cell death. To test this hypothesis,
we stably expressed a green fluorescent protein (GFP)-rat MAL fusion protein (GFP-rMAL)
construct in ETX resistant Chinese Hamster Ovary (CHO) cells (CHOGFP-rMAL), and identified
that these cells were able to bind Alexa-594 labeled ETX, while CHO cells transfected with GFP
alone (CHOGFP) did not bind the toxin (Fig 1A). Alexa-594 labeled ETX retained normal func-
tion in cytotoxicity assays (S1 Fig). To confirm and quantify binding of ETX to MAL express-
ing cells, we tested these two stably transfected cell lines by flow cytometry using Alexa-647
labeled ETX (laser 640nm/detector 675 nm). ETX showed robust binding to CHOGFP-rMAL
cells, while failing to bind to CHOGFP controls (Fig 1B). To assess the effects of ETX on cell via-
bility in CHOGFP-rMAL and CHOGFP cells, we designed an assay using PrestoBlue as a cell
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Fig 1. MAL expression in CHO cells is required to confer specific binding of ETX. Stable clones of CHO cells expressing either GFP (CHOGFP) or GFP-
rMAL (CHOGFP-rMAL) were assessed for binding with Alexa-594 labeled ETX (ETX594). (A) Confocal images of fixed CHOGFP or CHOGFP-MAL cells treated
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viability indicator. PrestoBlue is a resazurin-based cell permeable compound converted to the
fluorescently active resorufin in the reducing environment of metabolically active cells [65–67].
ETX killed CHOGFP-rMAL cells in a dose- and time-dependent fashion (Fig 1C). In contrast,
CHOGFP cells remained completely viable at all doses of ETX tested. In addition, we assessed
cell death using propidium iodide (PI) exclusion as an independent assay for cell death [68,
69]. CHOGFP or CHOGFP-rMAL cells were treated with 500 pM ETX 500pM and monitored for
PI uptake over a 24-hour period. By the 4-hour time point, we observed robust PI uptake in the
CHOGFP-rMAL but not the CHOGFP control cells (S2 Fig). By contrast, after 24 hours, PI uptake
remained undetectable in the CHOGFP controls. Taken together, these experiments support the
conclusion that MAL expression in ETX resistant cells is required to impart both binding and
sensitivity to toxin.
We next sought to determine the temporal relationship between ETX pore formation and
morphologic indicators of cell death. To accomplish this, we incubated CHOGFP-rMAL cells
with 50 nM ETX for increasing times and assessed both PI uptake and nuclear morphology. PI
has an estimated van der Waals volume of 447 cubic Å. The size of the propidium cation limits
passage of PI through membrane pores, and the van der Waals dimensions of propidium re-
quires a minimum diameter of 1.5 nm for a propidium-permeable pore [70]. Studies examining
the size and physical properties of the pores formed by ETX suggest an asymmetrical shape of
the pore with its larger radius at 1.0 nm [69, 71]. Therefore, the ETX heptameric pore is likely
permeable to PI. It has been previously shown that ETX induces permeability of MDCK cells
to PI, and that small molecule antagonists that do not block heptamerization but do block the
pore, inhibit PI entry into cells [66, 68, 72]. In addition to time-course, we examined the change
of localization patterns of MAL in response to ETX exposure. In untreated CHOGFP-rMAL cells
and for those treated with ETX for 5 minutes, MAL is localized primarily in the plasma mem-
brane with some perinuclear staining (Fig 2A and 2B). As shown, the complete exclusion of PI
indicates preserved membrane integrity in these cells. At 15 minutes of ETX treatment some
cells retain normal appearing plasma membrane morphology while others reveal disruption of
the plasma membrane and internalization of MAL into vesicles. Interestingly, those cells with
normal MAL localization on the plasma membrane completely exclude PI whereas cells with
disrupted membrane architecture and internalization of MAL are PI-positive (Fig 2C). Cells
that have incorporated PI show intense localization of PI in nucleoli and faint staining of mor-
phologically normal nuclei. By 30 minutes of treatment, the majority of CHOGFP-rMAL cells
shows disruption of the integrity of the plasma membrane and incorporation of PI (Fig 2D).
However, incorporation of PI at 30 minutes of treatment falls into one of two morphologic cat-
egories: intense staining of nucleoli with faint staining of morphologically normal nuclei, or in-
tense staining of condensed pyknotic nuclei characteristic of apoptosis. By 60 minutes of ETX
treatment, all the cells show disrupted plasma membranes and all of the PI staining is in pykno-
tic condensed nuclei (Fig 2E).
with 50 nM ETX594 for 60 minutes. Cells were washed and counter-stained with Hoechst (blue) to identify nuclei. There is essentially complete overlap of
ETX594 (red) and GFP-MAL (green) signals in cells expressing GFP-MAL. Note that GFP-MAL predominantly localizes to the plasmamembrane. In
contrast, there is no detectable ETX-594 signal in the cells expressing GFP, which is localized to the cytoplasm. (B) Flow cytometry analysis shows scatter
plots of living CHOGFP or CHOGFP-MAL cells incubated with 20 nM Alexa-647-ETX. Double positives (GFP and Alexa-647) are observed for CHOGFP-MAL but
not CHOGFP cells incubated with Alexa 647-ETX. Thus in both fixed (A) and live cells (B), MAL expression results in specific binding of ETX to the cell
surface. (C) ETX induces dose- and time-dependent cell death in MAL expressing cells. Cell viability was assessed using PrestoBlue as an indicator of
metabolically active cells. CHOGFP-rMAL expressing cells exhibit ETX sensitivity in a dose (upper panel) and time (lower panel) dependent fashion. CHOGFP
cells fail to exhibit ETX sensitivity at any of the administered doses or time points. Results were normalized to the fluorescent signal from cells incubated in
the absence of toxin (100%) and in 0.1% Triton X-100 (0%). Data shown are means and SD from a single experiment and are representative of four
independent triplicate experiments.
doi:10.1371/journal.ppat.1004896.g001
Epsilon Toxin Requires MAL for Binding and Toxicity
PLOS Pathogens | DOI:10.1371/journal.ppat.1004896 May 20, 2015 5 / 29
Fig 2. ETX induces rapid internalization of rMAL that precedes or coincides with cell death.CHO cells stably expressing GFP-rMAL (green) were
treated with 50 nM ETX in the presence of 2 μg/ml PI (red) and fixed at 0 minutes (A), 5 minutes (B), 15 minutes (C), 30 minutes (D), 60 minutes (E), and 90
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If MAL is the receptor or a direct biding partner for ETX, then the protein-protein interac-
tion is most likely to occur between the receptor binding domain of ETX and the extracellular
domain(s) of MAL. The primary structure of full-length MAL predicts a tetraspan integral
membrane protein with two extracellular loops, ECL1 and ECL2 [41, 51]. MAL shares 87–89%
of amino acid residue identity among human, rat, and dog (Fig 3). Sequence alignment
highlighting ECL1 and ECL2 for rat and human MAL reveals a single amino acid substitution
in each of the two domains (Fig 3). In contrast, zebrafish MAL shares significantly less amino
acid identity with either human or rat MAL, especially within ECL2. To determine if sequence
differences in MAL orthologues influence ETX binding and cytotoxicity, we first transiently
transfected CHO cells with vectors expressing human, rat, or zebrafish MAL and analyzed
binding by flow cytometry. ETX fails to bind to cells expressing either zebrafish MAL or GFP
control (Fig 4A). ETX binds to both human and rat MAL expressing cells but displays an ap-
proximate ten-fold increase in binding affinity for rat MAL when compared to the human
orthologue (Fig 4A). We then generated stable CHO cells lines expressing rMAL, hMAL, or
the GFP vector alone and tested these cells for sensitivity to ETX. Cells were treated with esca-
lating concentrations of ETX for 6 hours followed by live-imaging in the presence of PI to as-
sess pore formation and cell death. As shown, rMAL expressing CHO cells are markedly more
sensitive to ETX than those expressing hMAL (Fig 4B). The IC50 for ETX-induced cell death
was 0.6 nM for rMAL and 40 nM for hMAL. Notably, after 6 hours of treatment, rMAL-ex-
pressing CHO cells show evidence of cell death at 0.5 and 5.0 nM ETX, whereas those express-
ing hMAL are still PI- negative (Fig 4C).
To determine if disruption of the primary structure within ECL1 or ECL2 impacts
ETX binding to MAL, we generated stable cell lines expressing mutants of the human MAL
harboring the FLAG epitope in ECL1 or ECL2 [56], respectively designated hMAL-L1F and
hMAL-L2F (Fig 5A). We assessed targeting and orientation of the mutant proteins by fluores-
cence microscopy for both GFP and the FLAG epitope. Stable clones of hMAL-L1F-expressing
CHO cells were generated but these failed to reliably target to the plasma membrane and were
therefore not used in subsequent analyses. hMAL and hMAL-L2F are targeted to the plasma
membrane as well as show some peri-nuclear localization in both live (Fig 5B) and fixed cells
(Fig 5C). In live cultures the anti-FLAG antibody binds to hMAL-L2F expressing cells (Fig
5B). This indicates extracellular localization of the FLAG epitope and thus of ECL2, which is
consistent with previous description [56, 60]. We then assessed binding and localization of
Alexa-594 labeled ETX to cells expressing rMAL, hMAL, hMAL-L2F, and GFP control. Ex-
pression levels and subcellular localization patterns for all of three fusion proteins (rMAL,
hMAL, and hMAL-L2F) are similar, as shown by GFP fluorescence intensity and distribution
(Fig 5C). ETX binding is greater in magnitude for rMAL than for hMAL (Fig 5D). ETX
completely fails to bind to cells expressing hMAL-L2F, underscoring the potentially important
role of this domain in ligand interaction.
Having shown that the second extracellular loop of MAL is required for ETX binding, we
next tested the sensitivity of the cells expressing hMAL-L2F using PI exclusion as an assess-
ment of cell death. As previously noted, cells expressing rMAL were more sensitive to ETX in
minutes (F) following the treatment. Regions (c-e) framed in C-E are shown at a higher magnification to illustrate morphological details. Images in c-e are
shown in separate fluorescence channels and as an overlay plus a DAPI-counterstain. Hollow arrows in c point to the cells on which MAL is largely present
on the cell surface. Noticeably, these cells are negative for PI staining. The morphological heterogeneities likely reflect different phases of cell cycle in
individual cells within the population. Arrows in c and d point to the cells displaying intracellular vesicles of MAL protein, which indicate an ongoing MAL
internalization process in response to ETX. These are dying cells that exhibit PI inclusion in their nuclei with a higher staining density in nucleoli. Arrowheads
in d and e point to the dead cells that display condensed nuclei brightly stained with PI and contain intracellular MAL protein. Scale bars represent 20 μm.
Data shown are representative of at least three independent experiments.
doi:10.1371/journal.ppat.1004896.g002
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cell death assays than those expressing hMAL. Cells expressing hMAL-L2F are completely in-
sensitive to ETX and thus behave like GFP vector control cells (Fig 6). Even after 24 hours of
exposure to 50 nM ETX, hMAL-L2F expressing CHO cells show no evidence of cell death
(Fig 6). By contrast, the wild-type hMAL-expressing cells exhibit significant cell death after
6 hours of ETX exposure. Since the hMAL-L2F mutant protein is correctly targeted and orient-
ed within the plasma membrane, these results support a specific requirement for ECL2 in ETX
binding and cytotoxicity.
MDCK cells are possibly the most thoroughly studied ETX-sensitive cell line, and we there-
fore wanted to compare the binding and sensitivity of ETX between MDCK and MAL express-
ing CHO cells. ETX is a 29 KDa protein that heptamerizes [46, 48, 73] after binding to its cell
surface specific receptor, generating an asymmetric pore leading to ATP depletion and loss of
ion and water homeostasis [74]. To determine if MAL expression in CHO cells is required for
ETX heptamerization, we treated CHOGFP, CHOGFP-rMAL and MDCK cells with ETX and per-
formed Western-blot analysis of cell lysates for oligomerized ETX. As anticipated, treatment of
MDCK and CHOGFP-rMAL cells with ETX result in formation of an approximate 145 kDa com-
plex (Fig 7A) consistent with a heptameric pore [46, 73]. Both MDCK and CHOGFP-rMAL cells
show similar localization patterns of ETX binding to the cell surface (Fig 7B). We next deter-
mined the relationship between MAL expression level and ETX sensitivity by analyzing various
MDCK cell lines either sensitive or resistant to ETX (Fig 7C and 7D). MDCK (CCL-34) cells
were treated with a dose of ETX sufficient to kill>95% of the monolayer and individual surviv-
ing cells were recovered as a pool (MDCK-R) or as individual clonal populations (1E3 and
3C7). In addition, two additional MDCK cell derivatives (CRL-2935 and CRL-2936) were ac-
quired from ATCC. Sensitivity to ETX was determined by incubating cell monolayers with
Fig 3. Species variation in the amino acid sequence of MAL. Alignment analysis of human, rat, dog, and zebrafish MAL amino acid (aa) sequences was
performed with the multiple sequence alignment program ClustalW2 [100]. The sequence corresponding to the extracellular loop 1 (ECL1) and the
extracellular loop 2 (ECL2) is highlighted in yellow and green, respectively. The aa residues differed among human (red), rat (blue), and dog (brown) are
color-marked.
doi:10.1371/journal.ppat.1004896.g003
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Fig 4. Differential binding and cytotoxicity of ETX to cells expressing MAL orthologues. (A) FACS histogram of Alexa 647-labeled ETX binding to cells
transiently transfected with MAL expression vectors. As shown, ETX binds to cells expressing rMAL with greater affinity than to hMAL, whereas it fails to bind
to CHO cells transiently transfected with constructs expressing zebrafish MAL, hMAL-L2F, or the GFP vector alone (overlapping curves at far left of the plot).
(B) CHO cells stably expressing GFP-alone (vector), GFP-rMAL (rMAL), or GFP-hMAL (hMAL) were treated with ETX at concentrations ranging from 0 to
300 nM in the presence of 2 μg/ml PI (red) for 6 hours and live-imaged for assessing cell death. (C) Representative images show the ETX effect in GFP-rMAL
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serial dilutions of purified ETX (Fig 7C). In all cases ETX-sensitive MDCK cells express MAL
and ETX-resistant MDCK cells show no expression or negligible levels of MAL (Fig 7D).
Previous studies have shown that a group of closely spaced aromatic amino acid residues
within domain 1 of ETX are necessary for binding and toxicity to MDCK cells [44, 75, 76]. Spe-
cifically, glutamate substitutions at Y29, Y30, Y36 or F199 each result in loss of ETX binding,
pore formation and cytotoxicity [44]. At Y196, also within domain 1, glutamate substitution re-
sult in significantly reduced ETX activity [44]. Here, we tested whether these ETX mutations
similarly impact ETX toxicity in MAL-expressing CHO cells. Wild-type ETX (wt-Etx), mutant
toxin containing the Y30E substitution (Etx-Y30E), and mutant toxin containing the Y196E
substitution (Etx-Y196E) were examined, and rMAL- or hMAL-expressing CHO cells were
compared to MDCK cells in cytotoxicity assays (Fig 8). As controls, we included CHO cells
expressing the irrelevant tetraspan PLLP [77] as well as GFP vector alone. As expected, wild-
type toxin induces robust cell death in MDCK cells and in CHO cells expressing rMAL or
hMAL. rMAL-expressing CHO cells are more sensitive than MDCK cells, which exhibit greater
sensitivity than hMAL-expressing CHO cells. Consistent with published reports [44, 75, 76],
Y30 mutation (Etx-Y30E) completely abolishes ETX-induced cell death while Y196 mutation
(Etx-Y196E) significantly reduces ETX-toxicity in MDCK cells. Remarkably, the effects of
these ETX mutations on MDCK cells are essentially reproduced in MAL-expressing CHO
cells. Y30 mutation (Etx-Y30E) renders ETX ineffective in both rMAL- and hMAL-expressing
CHO cells. Intriguingly, while Etx-Y196E attenuates ETX effect approximately 10 folds in
rMAL-expressing CHO cells compared to Wt-Etx, this mutant toxin slightly increases ETX
toxicity in hMAL-expressing CHO cells. PLLP-expressing CHO cells are completely insensitive
to wild-type ETX, indicating the specificity of MAL for toxin activity. These findings demon-
strate that MAL expression alone is not only necessary to impart ETX toxicity in insensitive
naïve CHO cells but is also able to confer differential response to ETX mutants. Moreover, our
data suggest that ETX-MAL interaction involves the aromatic side chains in domain 1 of ETX
and the second extracellular domain of MAL.
We have so far provided evidence that introduction of MAL into ETX-resistant cells renders
them capable of binding to toxin and sensitive to its effects. We further showed that insertion
of the FLAG epitope into ECL2 results in loss of ETX toxicity. To elaborate on the loss-of-func-
tion strategy, we made use of the mice deficient in MAL (MAL-/-) [55], which exhibit no overt
physical or behavioral abnormalities but do have a defect in the maintenance of CNS paranodal
myelin loop structure [55]. We first investigated the behavioral responses of animals injected
with ETX using a detailed scoring system. Adult mice were injected via the tail vein with 5 ng
of ETX per gram of body weight and then placed under continuous observation for an hour.
The mean time for onset of symptoms following ETX administration is 11.8 minutes for wild-
type mice (Table 1), and all of the wild-type mice undergone ETX injection progressed rapidly
to a moribund state requiring euthanasia. None of the MAL-/- mice injected with ETX devel-
oped symptoms and they remain healthy throughout the next 48 hours after which they were
routinely sacrificed. Neither wild-type nor MAL-/- mice in the untreated control groups devel-
oped behavioral symptoms. In a second experiment, mice were injected with 50 ng of ETX and
videotaped. MAL-/-mice were completely resistant to ETX, whereas wild-type mice rapidly be-
came obtunded (S1 Movie).
2–5 month-old wild-type (MAL+/+) or MAL-Knockout (MAL-/-)mice were untreated
(control) or injected via the tail vein with ETX at the dose of 5 ng/gram of body weight. Time
(green) or GFP-hMAL-expressing CHO cells at critical concentrations. Scale bar represents 100 μm. Data are from a single experiment and are
representative of four independent triplicate experiments. Data shown in B are means and SD.
doi:10.1371/journal.ppat.1004896.g004
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until symptoms was recorded for the next hour. Data are means and SD from a single experi-
ment and are representative of two independent experiments
We next examined binding of ETX to tissues from wild-type and MAL-/- mice [55]. In
wild-type mouse tissues examined, Alexa-594-labeled ETX stains gut microvasculature, retinal
microvessels, renal tubules, CNS myelin, and squamous epithelium of the eye sclera (Fig 9).
However, ETX fails to stain these same structures fromMAL-/- mice (Fig 9). Staining of mark-
ers for CNS myelin (PLP), microvasculature and eye sclera epithelium (BSL1), and renal tu-
bules (Shiga toxin 1 beta) show no difference between wild-type and knockout mice. These
results indicate that MAL loss-of-function abrogates specific ETX binding in vivo.
Discussion
Is MAL the ETX receptor?
We have shown that introduction of the MAL gene imparts ETX sensitivity to previously in-
sensitive CHO cells, and that the characteristic responses of MDCK cells to ETX are shared by
MAL-expressing CHO cells. These cellular responses include cell surface binding of ETX, ETX
oligomerization and pore assembly, differential response to ETX mutant proteins according to
the nature of the mutations [43, 44, 76, 78], and cell death. Such remarkable consistencies led
us to speculate that MAL is either 1) the bona fide ETX receptor and interacts directly with
ETX via protein-protein interactions or 2) part of the ETX receptor complex and plays a role in
the sorting, chaperoning, and/or recruitment of a novel direct binding partner of ETX.
We employed several different experimental approaches to determine if ETX interacts di-
rectly with MAL, however, the results of these experiments were inconclusive. Numerous varia-
tions on traditional co-immunoprecipitation (co-IP) and far-Western blotting experiments
altering antibodies, salt concentrations and detergents yielded inconsistent results. One possi-
ble explanation for these inconsistences is that transmembrane proteins containing multiple
hydrophobic domains, as is the case of MAL, often possess different tertiary structures and
binding affinities when in solution relative to those occurring within a lipid bilayer [79]. Such
changes might confound solution-based analysis such as co-IP and far-Western detection or
even render physical interaction between ETX and MAL impossible in these conditions. We
also obtained negative results from far-Western blotting and fluorescence resonance energy
transfer (FRET) experiments. While FRET analysis was performed under physiologic condi-
tions with MAL in its native conformation within a lipid bilayer, molecular orientation and
physical distance between the relevant fluorophores on ETX and MAL could easily preclude
FRET detection. Investigation using other advanced methods for detecting protein-protein in-
teractions, including co-IP/protein mass fingerprinting and surface plasmon resonance biosen-
sor assays are currently underway. Our results thus far do not distinguish between a function
Fig 5. ETX binding requires the second extracellular loop of MAL. (A) Generation of cells stably expressing either hMAL or hMAL-GFP harboring a
FLAG insertion in its second extracellular loop (hMAL-L2F) fused with N-terminal GFP protein. (A) Schematic illustration of hMAL structure (upper panel) and
insertion of a 15 aa-sequence, which contains the FLAG epitope (DYKDDDDK) marked in red and a spacer sequence in dark bold (lower panel), in the
second extracellular loop (loop 2 or ECL 2) in hMAL. Amino acid residues within loop 2 are underlined. The diagram is adapted with modifications from our
previous publication [56]. (B) Confirmation of the FLAG tag in hMAL-L2F-expressing CHO cells by anti-FLAG antibody live staining. Scale bar represents
10 μm. (C andD) Representative images (C) and statistical analysis (D) show that expression of MAL is required for ETX binding, whereas insertion of a
FLAG segment in loop 2 of hMAL eliminates ETX binding. CHO cells stably expressing GFP-alone (vector), GFP-rMAL (rMAL), GFP-hMAL (hMAL), or GFP-
hMAL-L2F (hMAL-L2F) (green) were incubated with 25 nM Alexa 594-conjugated ETX (ETX-594, red) for 1 hour before fixation for fluorescence analysis. In
the second row images, arrows indicate cells on which MAL distribution and ETX-594 labeling occur largely on the cell surface; arrowheads indicate cells
undergoing MAL internalization, in which ETX-594 co-localizes with MAL on both the cell membrane and intracellular vesicles; asterisk indicate cells of which
the surface representation of MAL and ETX-594 is lost. Binding of ETX is quantitatively greater for cells expressing rMAL compared to hMAL. Scale bar
represent 20 μm. Data are from a single experiment and are representative of three (B) or four (C and D) independent triplicate experiments. Data shown in D
are means and SD.
doi:10.1371/journal.ppat.1004896.g005
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of MAL in direct binding of ETX versus a role of MAL in recruiting or organizing the ETX
receptor complex.
Fig 6. The second extracellular loop in MAL is critical to MAL-mediated ETX-cytoxicity. Representative images (top panels) and statistical analysis
(bottom panel) show that MAL expression renders cells sensitive to ETX-induced cell death in rat MAL (rMAL)-expressing or humanMAL(hMAL)-expressing
CHO cells, whereas insertion of a FLAG segment in loop 2 of hMAL (hMAL-L2F) blocks hMAL-mediated ETX-cytotoxicity. CHO cells were treated with PBS
(control) or 50 nM ETX and fixed at the indicated time points. 2 μg/ml PI (red) were included in the culture medium to monitor cell death. Similar levels and
patterns of GFP expression (green) in untreated (control) hMAL and hMAL-L2F cells suggest blockade of ETX-toxicity in the latter cells is a consequence of
structural alteration resulting from Flag insertion in loop 2. Scale bar represents 100 μm. Data are means and SD from a single experiment and are
representative of three independent triplicate experiments.
doi:10.1371/journal.ppat.1004896.g006
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Although we have been unable to determine if MAL interacts directly with ETX, theoretical
modeling suggests MAL may have the structural requirements to facilitate direct protein-to-
protein interaction. The primary structure of the extracellular loop 2 (ECL2) for MAL reveals a
Q to F substitution between human and rat respectively at position 114, a change from the
highly polar side chain of glutamine to the non-polar side chain of phenylalanine. Considering
the functional significance of aromatic side chains in the receptor-binding domain of ETX
[44], the aromatic residue in ECL2 for rMAL may contribute to additional aromatic stacking
interactions with residues in the receptor-binding domain of ETX [44]. If MAL is the binding
receptor for ETX, then the second ECL appears to play an essential role. Insertion of the FLAG
epitope into ECL2 leads to abrogation of both ETX binding and cytotoxicity while retaining
normal localization of MAL in the plasma membrane. Computer-aided analysis predicts that
the ECL2 FLAG sequence insertion changes structural dynamics of ECL2- particularly in the
aspect of protein surface accessibility. This, if experimentally proved, would suggest a central
role for ECL2 structural integrity in ETX binding and toxicity. Interestingly, previous studies
using the same construct show FLAG insertion in ECL2 neither alters the incorporation of
MAL into glycolipid-enriched membrane microdomains and lipid rafts [80], nor influences
MAL trafficking between the cell membrane and the trans-Golgi network [56]. That the FLAG
insertion in ECL2 results in loss of ETX binding and toxicity thus favors, but does not prove, a
direct role of MAL in transmitting ETX activity into target cells.
Despite MAL’s structural possibilities as the ETX receptor and the requirement of MAL for
both ETX binding and toxicity, it is possible that MAL is not the direct binding receptor for
ETX. MAL could be functioning in ETX binding either as a co-receptor, part of a multmeric
protein complex, or as a membrane lipid micro-domain organizer necessary for assembly of
the receptor complex, without directly binding to ETX. The lethal effects of C. perfringens ETX
require first, binding of ETX monomers to a specific cell surface receptor; second, oligomeriza-
tion into a prepore complex; and third insertion of the stable pore into the plasma membrane
culminating in the free passage of ions and water and thus loss of electrochemical gradients es-
sential for cell viability [46–48, 73]. MAL could play a role in any of these required steps with-
out directly interacting with ETX. Indeed, MAL is known to localize to the apical surface or
within specialized microdomains of particular polarized cells [49, 53, 56–60, 63, 80–83]. Locali-
zation of MAL on cell surface and MAL’s role in protein sorting provide the ideal localization,
microenvironment and cellular machinery for ETX to target and damage cells [54, 55, 58, 64,
82, 84].
Fig 7. ETX pore formation, subcellular localization, and toxicity in cells are closely associated with MAL expression. (A) Formation of ETX pore
complexes in MDCK cells and rMAL-expressing CHO cells. Western-blots of cell extracts treated with active ETX (+) or control buffer (-) for 1 hour at 37 C°.
Detergent resistant membranes were isolated from ETX or control treated cells and solubilized in Lamelli buffer under non-reducing conditions without
heating. Treatment of CHOGFP-rMAL cells with active ETX leads to formation oligomeric complexes (GFP-rMAL) that do not form in ETX treated CHOGFP cells
(GFP) or mock transfected CHO cells (Mock). The relative molecular weight (MW) of the oligomeric complex formed in CHOGFP-rMAL cells is similar to the size
of the ETX oligomeric complex formed with ETX treatment of MDCK cells (MDCK), shown at 145 kDa on the blots. ETX monomer runs at 29 kDa. (B) ETX co-
localizes with MAL on the cell membrane, and binds to MAL-expressing CHO cells and MDCK cells in a similar pattern. CHO cells stably expressing GFP-
vector or GFP-rMAL fusion protein (GFP-rMAL) and MDCK cells were incubated with 25 nM ETX-594 conjugate (red) for 30 minutes before fixation for
fluorescence analysis. DAPI (blue) were counterstained to reveal cell nuclei. Arrowheads point to CHO cells displaying co-localized ETX-MAL intracellular
vesicles indicative of ongoing internalization. Scale bar represent 20 μm. (C andD) ETX sensitivity correlates with MAL expression levels in MDCK cells. Cell
viability assays (C) show that various MDCK cell lines or cell culture manipulations exhibit different sensitivity to ETX-induced cell death. MDCK (CCL-34)
cells were treated with a dose of ETX sufficient to kill >95% of the monolayer and individual surviving cells were recovered as a pool (MDCK-R) or as
individual clonal populations (1E3 and 3C7). In addition, two additional MDCK cell derivatives (CRL-2935 and CRL-2936) were acquired from ATCC.
Sensitivity to ETX was determined by incubating cell monolayers with serial dilutions of purified ETX. Quantitative RT-PCR analysis (D) shows that ETX-
sensitive cells exhibit significantly higher levels of MAL expression compared to the cell lines resistant to ETX treatment. Data are from a single experiment
and are representative of four (A), three (B), or at least three (C and D) independent triplicate experiments. Data shown are means and SD. Comparisons
between MDCK and the other cell lines were performed by ANOVA followed by Dunnett’s post hoc test. * P<0.05.
doi:10.1371/journal.ppat.1004896.g007
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Previous studies show that HAVCR1 is required, at least partially, for ETX-mediated cyto-
toxicity [37, 44]. HAVCR1 increases the sensitivity of cells to ETX if they are already sensitive
Fig 8. Specific aromatic residues within domain 1 of ETX are required for toxin activity in MAL-expressing CHO cells. The plots on the left show the
cytotoxicity results on MDCK cells, CHO cells expressing rMAL or hMAL, and the two control CHO lines (GFP and the tetraspan PLLP). Cells expressing
rMAL and MDCK cells show similar sensitivity to ETX whereas the cells expressing hMAL are less sensitive. The Y30Emutant eliminates ETX toxicity in all
cell lines, while the Y196E mutant significantly attenuates the toxin activity in MDCK cells and rMAL cells. The plots on the right compare the same data by
cell line rather than by toxin. On both MDCK and on cells expressing rMAL, about 10-fold greater amounts of Y196E versus wt-ETX are required to kill cells.
In contrast, with cells expressing hMAL, there is little difference between the wt-ETX and the Etx-Y196E mutant. Data are means and SD from a single
experiment and are representative of three independent triplicate experiments.
doi:10.1371/journal.ppat.1004896.g008
Table 1. Symptom-onset time following ETX administration in mice.
Genotype Treatment Number of mice Symptom-onset time
MAL+/+ Control 5 None observed
MAL+/+ ETX 8 11.8 ± 2.9 min
MAL-/- Control 4 None observed
MAL-/- ETX 5 None observed
doi:10.1371/journal.ppat.1004896.t001
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to the toxin. However, HAVCR1 expression alone is insufficient to confer ETX sensitivity
upon cell lines resistant to the ETX effect. Also, both ETX binding and ETX-mediated cell
death occur in the absence of HAVCR1. Moreover, ETX binding with HAVCR1 on cell surface
has not been demonstrated [37]. In contrast, cells insensitive to ETX become completely sensi-
tive when MAL expression is induced. In addition, ETX binds to the MAL-expressing cell
membrane surface and becomes internalized in a time-dependent fashion. Thus, MAL seems
to play a more central role than HAVCR1 in the context of ETX binding and toxicity. It would
Fig 9. MAL is necessary for ETX binding in vivo. Alexa-594-conjugated-ETX binds to tissue from wild-type
mice but not MAL-/- mice. (A)Mice were injected intravenously with Alexa-594-conjugated-ETX (red) and
BSL1 (green), a pan endothelial cell marker, followed by PBS perfusion. ETX (red) binds to vascular
endothelium of the small intestine in wild-type mice but not MAL-/- mice. To evaluate ETX binding to retinal
vessels (B), kidney (C), CNS white matter (D), and squamous epithelium of the eye sclera (E), tissue sections
were probed with Alexa-594-conjugated-ETX (red). ETX binds to tissue from wild-type mice but not MAL-/-
mice. BSL1 (green) was stained in (A), (B), and (E) to identify endothelial cells. Shiga toxin (STX1B)-488
(green) was used to identify kidney tissue in (C). The myelin marker PLP (green) was stained to identify
myelin structures in the brain in (D). Note that on the brain section (D), ETX shows nearly complete overlap
with myelin stains. The corpus callosum (cc), which is the major white matter tract in the brain, is marked.
DAPI (blue) was counterstained to identify cell nuclei. Data are representative of at least three
independent experiments.
doi:10.1371/journal.ppat.1004896.g009
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be interesting to determine whether MAL is physically and/or functionally linked to HAVCR1
in this context.
Taken together, we have identified, for the first time, a protein that is required for both
binding and activity of ETX to cells. These results provide novel insights on how this toxin in-
teracts with host cells. Since ETX is responsible for a devastating disease in livestock and may
be a possible environmental factor contributing to the initiation of new MS lesion formation,
understanding the molecular basis of toxin binding to cells and cytotoxicity opens investigation
into new treatment strategies.
Does MAL structure and function make sense for enhancing ETX pore
formation?
The normal physiological function of MAL in apical sorting of proteins to specialized lipid
rafts affords the ideal context for a pore-forming toxin. ETX oligomerization requires close
proximity of monomers to facilitate interaction between amphipathic residues within domain
3 of the active toxin [43]. Highly concentrated MAL within lipid rafts favors these necessary
protein-protein interactions by bringing MAL-bound toxin monomers within binding range of
one another [54, 55, 58, 64, 82, 84]. Intriguingly, MAL itself has been shown to self-oligomerize
[64], which may further support ETX oligomerization and pore formation. The same mem-
brane biophysical characteristics achieved within the lipid raft microenvironment that enhance
endosome formation also appear to enhance pore formation. Lipids that favor spontaneous
negative curvature in bilayers such as cholesterol, diacylglcerol, long-chain unsaturated fatty
acids, glycosphingolipids and phosphatidylethanolamine are enriched in lipid rafts and have
been shown to enhance ETX pore formation [34, 36]. Caveolins 1 and 2, essential scaffolding
proteins localized to lipid rafts, promote formation of caveolae and are necessary for oligomeri-
zation of ETX and pore formation [85]. In essence, the MAL microenvironment is well suited
for a pore-forming toxin that requires oligomerization.
What accounts for the variability in ETX pathogenicity between species?
Why are the pathological effects of ETX so variable between species? In part, this occurs due to
known differences in the kinetics of bacterial growth within the gastrointestinal tracts of species
with fermenting 4-chamber stomachs (ruminant) and the linear gut of the rodent or human [3,
7, 86–98]. A second level of difference explaining the distinct pathologic effects of ETX between
species is receptor affinity. The binding receptor for ETX remains undefined. In this report we
have shown that MAL is required for both ETX binding to cells and for cellular toxicity. Inter-
estingly, the binding affinity and the susceptibility of cells to cytotoxic effects of ETX vary dra-
matically between rodent and human. Cells expressing human MAL bind ETX with
approximately 1/10 the affinity of cells expressing rat MAL, and cells expressing zebrafish
MAL do not bind ETX at all. The differences in affinity and cytotoxicity of ETX for cells ex-
pressing different MAL orthologues offers an additional level of complexity for the remarkable
differences in toxin mediated pathologies between species. It will be of interest to test the rela-
tive binding affinity of ETX to MAL from a wide range of species.
Materials and Methods
Ethics statement
All animal work was conducted according to federal guidelines and approved by the Weill Cor-
nell Medical College Institutional Animal Care and Use Committee.
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Generation of MAL constructs
The pβ-actin-EGFP-rat MAL (rMAL) and human MAL (hMAL) constructs and hMAL har-
boring a FLAG sequence insertion in its second extracellular loop (hMAL-L2F) have been pre-
viously published [56, 58]. hMAL and hMAL-L2F were subcloned and inserted into the N-
terminal of GFP gene in the pβ-actin-EGFP vector. hMAL with a FLAG insertion in the first
extracellular loop (hMAL-L1F) was synthesized with RsrII/XbaI restriction sites, and pur-
chased from Genewiz, Inc. A plasmid encoding zebrafish MAL was purchased from ATCC,
subcloned and inserted into the pβ-actin-EGFP vector. The pEGFP-C1 vector was purchased
from Addgene and used as the GFP control. All plasmids were amplified and purified (Qiagen)
in One Shot Top 10 Escherichia coli (Life Technologies). Sequence analysis and verification was
performed (Macrogen USA).
ETX
ETX and pro-ETX are provided by BEI at a minimum> 95% purity. Each lot was provided
with a certificate of analysis including a Western-blot, which showed a dominant band at ~30
kDa. In some lots, a faint low molecular weight band was also observed. Importantly, use of an
ETX specific neutralizing antibody completely abrogated the cell death-inducing activity of the
reagent underscoring its purity.
Fluorophore labeling of ETX/pro-ETX
His-tagged ε-prototoxin was procured from BEI Resources. One mg was fluorescently labeled
using Alexa Fluor 594 Protein Labeling Kit (Life Technologies) and 1 mg was labeled using
Alexa Fluor 647 Protein Labeling Kit (Life Technologies) as per manufacturer's instructions.
His tagged Shiga toxin 1β was procured for BEI Resources and fluorescently labeled using
Alexa Fluor 488 Protein Labeling Kit (Life Technologies).
Expression and purification of recombinant ε -prototoxin
Expression and purification of recombinant wild-type and mutant ε-prototoxins were per-
formed as described previously [44, 72]. Purified ε-prototoxins were treated with trypsin-coat-
ed agarose beads and conversion of the prototoxin to active toxin was assessed based on
SDS-PAGE and immunoblotting with anti-ETX antibodies [37].
Cell culture and transfection
Chinese hamster ovary (CHO) cells (ATCC Cat#CCL-61) were grown in Dulbecco's Modified
Eagle's Medium/Ham's F12 medium (Life Technologies) with 10% heat-inactivated fetal bo-
vine serum, 50 units/ml penicillin and 50 μg/ml streptomycin. CHO cells were transfected with
the indicated expression plasmids using Turbofect (Fermentas) according to the manufactur-
er’s instructions. For stable cells, clumped cells were collected after transfection and growth in
media containing G418 400 μg per ml for three weeks. Cells were then analyzed under a fluo-
rescence microscope for GFP expression. Homogenous GFP expressing cells were selected
using a Becton-Dickinson Vantage cell sorter. Colonies derived from single cells were viable
and expanded to generate frozen stocks. MDCK cells were routinely cultured in Minimum Es-
sential Medium (MEM) supplemented with glutamax (Life Technologies) and 10% FetalClone
III serum (HyClone) and incubated at 37°C in 5% CO2.
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Cell viability assays
PrestoBlue assay. Stably transfected rat GFP-MAL (CHOGFP-rMAL) and GFP (CHOGFP)
cells were grown in 384-well plates and incubated with ETX overnight. PrestoBlue Reagent
(Life Technologies), which is quickly reduced by metabolically active cells to a red fluorescent
metabolite, was added to each well using a multi-drop liquid dispenser. Fluorescence intensity
was measured with a microtiter plate reader (Perkin-Elmer Envision). For cytotoxicity analyses
of MDCK cells, cells were plated in Leibovitz L-15 medium supplemented with 10% fetal bo-
vine serum at a density of 5×103 cells per well in 384-well plates [66]. ETX was added and the
cells were incubated at 37°C overnight. Cytotoxicity was determined by treating cells with resa-
zurin (CellTiter Blue, Promega) at 37°C for 4 hours. Fluorescence was measured at 590 nm fol-
lowing excitation at 560 nm using a BioTek FLx800 plate reader. Results were normalized to
the fluorescent signal from cells incubated in the absence of toxin (100%) and in 0.1% Triton
X-100 (0%).
Propidium iodide (PI) uptake assay. Cell membrane permeability was assessed by the
ability of cells to exclude the DNA-binding fluorescent dye PI. Specifically, CHO cells stably ex-
pressing GFP, GFP-rMAL (rMAL), GFP-hMAL (hMAL), or GFP-hMAL-L2f were treated in
triplicate wells for each condition indicated in the experiments. Live images of randomly cho-
sen fields in each well were acquired under an inverted fluorescence microscope (Nikon)
equipped with a CCD camera (Carl Zeiss), and were then imported into ImageJ64 (NIH) in
8-bit grey format. For quantification of PI-positive cells, the images were converted into binary
images by applying the same threshold value to all images collected from the same experiment.
Analyze Particles function was selected to automatically count the particle numbers and to ana-
lyze particle properties, such as size shape, and distribution patterns. Data were exported into
Excel (Microsoft) and statistical significance was assessed by two-tailed student’s t-test. In the
experiment indicated, the toxin dose required to kill 50% of the cells (IC50) was determined by
nonlinear regression analysis in Prism (GraphPad Software).
Flow cytometry
Transfected cells were removed from the tissue culture substrate by incubating with citric saline
(135μM potassium chloride, 15μM sodium citrate dissolved in sterile water) for 5 minutes at
37°C. Cells were washed off the plate and then triturated into single cell suspensions. Cells
were washed 3 times with DMEM without phenol red (Life Technologies), containing 10%
fetal calf serum, 50 U/ml penicillin, and 50mg/ml streptomycin. Cells were diluted to 5x105/ml
and incubated with 20 nM Alexa 647-labeled ETX for 1 hour at 37°C. Labeled cells were
washed 3 times in DMEM lacking phenol red, and read on a AccuriC6 flow cytometer (BD
Biosciences).
Fluorescence microscopy
Cells stably transfected with rat MAL (CHO-MAL) or GFP (CHO-GFP) were plated on glass
bottom dishes (Mattek) at a density of 6x104 cells/ml, and allowed to grow overnight. Cells
were subsequently washed and fixed with 4% PFA for 10 minutes at room temperature (RT).
Cells were washed and incubated with Alexa 594 labeled ETX (50nM) for 1 hour at RT. After
incubation, the cells were washed 3 times in PBS and Hoechst (1μg/ml) was added for visuali-
zation of nuclei. Stained cells were visualized by confocal microscopy at the Rockefeller Univer-
sity Bio-Imaging Facility.
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Analyses of ETX binding and ETX-MAL co-localization
CHO cells stably expressing GFP, GFP-rMAL, GFP-hMAL or GFP-hMAL-L2F cultured in
triplicated wells were incubated with ALexa 594-labeled ETX (ETX-594) for an hour. In some
experiments, MDCK cells were incubated with ETX-594 for 30 minutes. Cells were fixed then
with 4% PFA for 10 minutes at RT and were subsequently mounted onto slides in VECTA-
SHIELD mounting medium containing DAPI (Vector Laboratories). Digital images were ac-
quired under Axiskop2 fluorescence microscope (Carl Zeiss) coupled with a SPOT cooled
camera (Diagnostic Instruments) and were imported into ImageJ64 (NIH) in 8-bit grey format.
Images for GFP-expression and ETX-binding intensity analyses were processed in separate
channels and converted into binary images by applying the same respective threshold values.
Measurement was automatically performed on the binary images for mean and integrated fluo-
rescent density. Data were exported into Excel (Microsoft) for statistical analysis.
FLAG expression analysis
CHO cells stably expressing GFP-hMAL or GF-hMAL-L2F were incubated with the anti-
FLAG antibody (Sigma) at 37°C for 10 minutes, followed by two quick washes with Hank's Bal-
anced Salt Solution (HBSS, Life Technologies). Cells were fixed with 4% PFA at RT for 10 min-
utes and then mounted onto slides in VECTASHIELD mounting medium with DAPI (Vector
Laboratories). Images were acquired under Axiskop2 fluorescence microscope (Carl Zeiss)
coupled with a SPOT cooled camera (Diagnostic Instruments) and processed in Photoshop
(Adobe).
MAL expression in cell lines
Total RNA was isolated from cells with TRIZol reagent (Life Technologies). Complementary
DNA (cDNA) was prepared from 2 μg total RNA using iScript cDNA synthesis kit (Bio-Rad).
Quantitative real-time PCR was performed using a MAL-specific primer set from Applied Bio-
systems and a StepOne Plus instrument (Applied Biosystems). A primer set specific to 18S
rRNA was used as control. Results were analyzed by comparing CT values [99].
Western-blot analysis of the ETX complex
MDCK, CHOGFP-rMAL, CHOGFP and mock transfected CHO cells (CHOmock) cells were grown
in 6- well plates (Costar) until confluence. Activated ETX (60nM) or vehicle control was ad-
ministered to cells and allowed to incubate for 1 hour at 37 C°. Cells were detached from plate
following trypsin digestion. Cells were collected, washed 3 times in PBS and re-suspended in
PBS containing 0.2% SDS. Harvested cells were then triturated with a serological pipette fol-
lowed by trituration with an insulin syringe until DNA was sufficiently sheared. ETX complex
containing detergent resistant membranes was isolated by centrifugation at 14, 000G for 5 min-
utes and collecting the pellet. The pellet was washed 3 times in PBS and re-suspended in 100 ul
PBS. An equal volume of 2 X Lamelli sample buffer (Bio-rad) was added to each sample for
SDS page electrophoresis. Proteints were transferred to an Immobilon-P membrane (Milli-
pore) and probed with a custom rabbit anti-ETX antibody generated against the N terminal of
ETX sequence KASYDNVDTLIEKGR (Pacific Immunology). HRP conjugated donkey anti-
Rabbit IgG (Jackson Immunoresearch) was used to visualize the ETX complex.
Immunofluorescence analysis with mouse tissues
Brain. Fresh frozen tissue sections were fixed in 4% PFA for 10 minutes at RT, permeabi-
lized in a 1% sodium cholate, 1% BSA, 10% donkey serum, PBST solution overnight at 4°C16.
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Sections were then incubated with rabbit anti-PLP (ThermoScientific) at 1:1000 overnight at
4 C°. Following three washes with PBS, sections were then incubated with donkey anti-rabbit
Alexa 488 (Jackson ImmunoResearch) at 1:1000, and Alexa 594 labeled His-tagged protoxin
(50nM) for 2 hours at RT.
Retina/eye. Fresh frozen tissue sections were incubated with BSLI (Vector Labs) 1:200,
and Alexa 594 labeled His-tagged protoxin (50 nM) for 1 hr at RT. After three 5-minute washes
in PBS, stained sections were post fixed in 4% PFA for 10 minutes at RT.
Kidney. Fresh frozen tissue sections were fixed in 4% PFA for 10 minutes at room temper-
ature, washed and incubated with Alexa 488 labeled His-tagged Shiga toxin 1β (200 nM) and
Alexa 594 labeled His-tagged protoxin (50 nM) for 1 hour RT.
The above stained tissues were washed 3 times in PBS, mounted and imaged under Axis-
kop2 fluorescence microscope (Carl Zeiss) coupled with a SPOT cooled camera (Diagnostic
Instruments.
Intestines. Anesthetized wild-type and MAL-/- mice were injected intravenously via tail
vein injection with 1ug Alexaflour 594 labeled active ETX and 1.6 μl FITC-conjugated BLS1
(Vector Laboratories) per gram of mouse. After ten minutes, mice were euthanized by cardiac
perfusion with PBS. Tissue was removed and fresh frozen in OTC.
Mouse lines
MAL-deficient mice (MAL-/-) were generated by replacing the first exon of theMAL gene with
the lacZ gene sequence [55]. MAL-/- mice were backcrossed with C57 / Bl6 mice for more than
six generations. MAL-deficient mice bred normally and had a normal life span.
ETX toxicity in mice
Animal handling. All animal work was conducted under an approved WCMC animal
protocol. Each mouse received ETX via intraperitoneal injection. Animals were injected once
IP with the dose of ETX indicated or with vehicle. Behavior was monitored every 15 minutes
for the first 2 hours and every half hour for the next six hours. If animals showed signs of severe
neurological toxicity (see below) then they were sacrificed by a lethal injection of Ketamine/
Xylazine (450 mg/kg Ketamine IP: 45 Xylazine mg/kg IP).
Scoring system and actions for humane care of animals. For all animals a medical record
and a neurological scoring chart was kept. For neurological signs the scoring system used was
the same as for experimental allergic encephalomyelitis experiments. The scoring system was
as follows: 0: No abnormality. Action: Continued monitoring. 1: Initial signs but no parapar-
esis. This included clumsiness, incontinence, flaccid tail. Action: Moistened food and hydration
packs were added to the cage bottom. Continued monitoring. 2: Mild paraparesis: Character-
ized by trouble initiating movement, but walking well once started. Action: Affected mice were
fed with moistened food and gel hydration packs. Continued monitoring. 3: Moderate parapar-
esis: Characterized by an inability to move one or both hindlegs, noticeable gait disturbance,
and possible atonic bladder. Action: Moistened food and hydration packs were placed on floor
of cage. Expressed urinary bladder if necessary. Supplemental heat if necessary. 4: Moderate
quadraparesis: Characterized by weakness in all limbs, associated gait disturbance and possible
atonic bladder. Animals could still move and feed from moistened food or hydration packs. Ac-
tion: Moistened food and hydration packs were placed on the cage floor. Animals in this state
were monitored every 15–30 minutes. The urinary bladder was manually expressed if needed.
Animals were provided an external means of heat, if needed (heat lamp, Safe and Warm, nest-
lets with additional bedding). If animals were unable to move or unable to feed, then they were
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euthanized immediately. 5: Moribund: Characterized by an inability to move even with prod-
ding, inability to feed, or labored respirations. Action: Euthanized immediately.
Data analysis and statistics
In most experiments, data were analyzed with Excel (Microsoft) and statistical significance was
assessed by two-tailed student’s t-test.  p< 0.05;  p< 0.01;  p< 0.001. In MAL expres-
sion analysis, statistical different between samples were performed by ANOVA followed by
Dunnett’s post hoc test.  P<0.05. In experiments determining ETX IC50 on vector-,rMAL- or,
hMAL-expressing CHO cells, nonlinear regression analysis was performed in Prism (Graph-
Pad Software).
Accession numbers
Rat (Rattus norvegicus) myelin and lymphocyte mRMA/Mal NM_012798, Rat Mal protein
NP_036930, Human (Homo sapiens) MAL mRNA NM_002371, Human MAL protein
NP_002362, Dog (Canis lupus familiaris) Mal mRNA NM_001003253, Dog Mal protein
NP_001003253, Zebrafish (Danio rerio) MAL-like protein mRMA NM_001017686, Zebrafish
Mal-like protein NP_001017686, epsilon-toxin (Clostridium perfringens B strain ATCC 3626)
gene ABDV01000020.1, epsilon-toxin protein EDT23265.1
Supporting Information
S1 Fig. Alexa-594-conjugated ETX retains toxicity in MAL-expressing CHO cells. CHO
cells stably expressing rMAL were exposed to either purchased activated ETX from BEI (ETX,
top row), Alexa-594 conjugated ε-ptotoxin (proETX-594, middle row), or trypsin-activated
Alexa-594 conjugated pro-ETX (TA ETX-594, bottom row) for 1 hour and cell viability was as-
sessed by PI (red) inclusion. Tyrpsin-activated Alexflour-594 conjugated pro-ETX exhibited
similar cytotoxic activity as the purchased activated toxin from BEI, whereas protoxin has no
effect on cell viability. Note that at the indicated concentrations, fluorescence from proETX-
594 or TA ETX-594 binding is not detectable, allowing visualization of signals from PI-positive
cells. Data are representative of at least three independent experiments.
(TIF)
S2 Fig. Time-course of ETX-induced cell death in MAL-expressing cells. CHO cells stably
expressing rMAL (CHOGFP-rMAL) or GFP-alone (CHOGFP) were treated with active ETX at the
concentration of 500 pM for the times indicated and then incubated with PI. Live cultures were
then examined for PI uptake (red) and GFP (green) by epifluorescence. CHOGFP-MAL but not
CHOGFP cells become permeable to PI 2 hours after ETX treatment. CHOGFP cells remain re-
sistant to ETX pore formation even after a 24-hour incubation. Scale bar represents 125 μm.
Data are representative of at least three independent experiments.
(TIF)
S1 Movie. MAL is necessary for ETX toxicity in vivo. A wild-type mouse (foreground) that
has received 50 ng of ETX via intraperitoneal injection (i.p.) lays obtunded. By contrast, a
MAL-/- mouse (background) injected, i.p., with 50 ng of ETX remains fully alert and unaffect-
ed. Data are representative of four independent experiments.
(MOV)
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